The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment

The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment

Abstract Patients with chronic kidney diseases (CKD) are often treated with antiplatelets due to aberrant haemostasis. This study aimed to evaluate the bleeding risk with CKD patients undergoing pentoxifylline (PTX) treatment with/without aspirin. In this retrospective study, we used Taiwan’s Nation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jing-Hung Fang, Yi-Chen Chen, Chung-Han Ho, Jui-Yi Chen, Chung-Hsi Hsing, Fu-Wen Liang, Chia-Chun Wu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/a770523e0df6497e8fc1816ef4e748e7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares